Nrf2 activation rescues stress-induced depression-like behaviour and inflammatory responses in male but not female rats

Ryan T. McCallum,Rachel-Karson Thériault,Joshua D. Manduca,Isaac S. B. Russell,Angel M. Culmer,Janan Shoja Doost,Tami A. Martino,Melissa L. Perreault
DOI: https://doi.org/10.1186/s13293-024-00589-0
2024-02-14
Biology of Sex Differences
Abstract:Major depressive disorder (MDD) is a recurring affective disorder that is two times more prevalent in females than males. Evidence supports immune system dysfunction as a major contributing factor to MDD, notably in a sexually dimorphic manner. Nuclear factor erythroid 2-related factor 2 (Nrf2), a regulator of antioxidant signalling during inflammation, is dysregulated in many chronic inflammatory disorders; however, its role in depression and the associated sex differences have yet to be explored. Here, we investigated the sex-specific antidepressant and immunomodulatory effects of the potent Nrf2 activator dimethyl fumarate (DMF), as well as the associated gene expression profiles.
genetics & heredity,endocrinology & metabolism
What problem does this paper attempt to address?